| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |